Indeed, treatment-naïve melanoma cells plated on ECM autonomously produced and assembled by dedifferentiated resistant or TT-exposed melanoma cells are protected from the anti-proliferative effect elicited by oncogenic BRAF inhibition [13]. Here, BRAF is linked to melanoma.